Novartis stands as a global leader in the pharmaceutical industry, dedicated to reimagining medicine to improve and extend people’s lives. With a strong commitment to innovation, Novartis strives to empower patients, healthcare professionals, and societies in the face of serious diseases. Novartis medicines reach over 250 million people worldwide, reflecting the company's extensive global reach and impact. The primary address of Novartis is at Novartis Campus, Basel, Baselstadt 4002, CH, with additional locations including One Health Plaza, East Hanover, NJ 07936, US, and Calle 93B S-31, Bogota, Bogota, D.C. 110541, CO.
Novartis focuses on developing innovative treatments and healthcare solutions across a range of therapeutic areas, including gene & cell therapy, solid tumors, radioligand therapies, cardiovascular diseases, immunology, chemistry, neuroscience, xRNA, and hematology. The company's dedication to research and development drives the creation of groundbreaking medicines that address unmet medical needs and improve patient outcomes. Novartis is committed to making a significant difference in global healthcare.
Novartis continues to expand its reach and impact through strategic collaborations and a patient-centric approach. The company's global presence allows it to address diverse healthcare challenges and contribute to the well-being of communities around the world. Discover more about Novartis and its commitment to innovation at http://www.novartis.com. We invite the manager of Novartis to create a customized and exclusive company showcase and product listing on our platform.
Compare Novartis with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
NovartisMain Company |
Boston Clinical Labo...View Profile |
Novartis PortugalView Profile |
Novartis in SloveniaView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1999 | 1996 | 0 |
|
Company Size
|
— | 11-50 | 201-500 | 1,001-5,000 |
|
City
|
Basel, Baselstadt | Waltham, MA | Oeiras, Porto Salvo | Ljubljana, Ljubljana |
|
Country
|
United States | Portugal | Slovenia | |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Pharmaceuticals
Healthcare
Drug Development
Biotechnology
Gene Therapy
Oncology
Cardiovascular
Gene & cell therapy
Solid Tumors
Radioligand
Immunology
Chemistry
Neuroscience
xRNA
Hematology
|
8 Total
8 Unique
Unique Skills:
Bacteriology
Cytology
Endocrinology
Histopathology
Serology
Special Chemistry
+2
|
13 Total
3 Common
10 Unique
Match
20%
Common Skills:
Healthcare
Oncology
Pharmaceuticals
Unique Skills:
Biosimilars
Dhermatology
Disease
Generics
Healthcare Solutions
Infectious
+4
|
13 Total
2 Common
11 Unique
Match
13%
Common Skills:
Oncology
Pharmaceuticals
Unique Skills:
Cell & Gene Therapy
Data & Digital
Dhermatology
Disease
Infectious
Innovation
+5
|
Other organizations in the same industry
This company is also known as